Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ai |
RCV002224727 | SCV002502801 | likely pathogenic | not provided | 2021-11-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496166 | SCV002788056 | likely pathogenic | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-11-06 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV003339936 | SCV004048077 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2J | criteria provided, single submitter | clinical testing | The stop gained variant c.77185A>T (p.Lys25729Ter) in TTN gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is present in the gnomAD exomes database with a frequency of 0.003%. The nucleotide change in TTN is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. |